CABA
Cabaletta Bio, Inc.Company with tickers: CABA
CIK
1759138
CUSIP
12674W109
Shares Outstanding
163,054,796
13F Activity (30d)
105 filings
105 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $37,136,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $29,018,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-37,136,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-35,943,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.71 | USD/shares | 2025-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.71 | USD/shares | 2025-03-31 | 10-Q | 2026-05-14 |